T1	Chemical	39 78	combined estrogen - progestin therapy (
T2	Chemical	79 87	EPT ) at
T3	Disease	118 135	breast cancer was
T4	Limited_variation	192 202	013 in SLC
T5	Gene_or_protein	202 215	O1B1 ( P = 0.
R1	influences	Arg1:T1	Arg2:T2
R2	treats	Arg1:T1	Arg2:T3
R3	isEquivalentTo	Arg1:T2	Arg2:T1
R4	treats	Arg1:T2	Arg2:T3
R5	isAssociatedWith	Arg1:T2	Arg2:T4
R6	isAssociatedWith	Arg1:T2	Arg2:T5
R7	isAssociatedWith	Arg1:T3	Arg2:T1
R8	isAssociatedWith	Arg1:T3	Arg2:T2
R9	isAssociatedWith	Arg1:T3	Arg2:T4
R10	isAssociatedWith	Arg1:T3	Arg2:T5
R11	influences	Arg1:T4	Arg2:T1
R12	isAssociatedWith	Arg1:T4	Arg2:T2
R13	isAssociatedWith	Arg1:T4	Arg2:T3
R14	isAssociatedWith	Arg1:T4	Arg2:T5
R15	influences	Arg1:T5	Arg2:T1
R16	influences	Arg1:T5	Arg2:T2
R17	isAssociatedWith	Arg1:T5	Arg2:T3
R18	isAssociatedWith	Arg1:T5	Arg2:T4
